Cargando…
A method for confirming a third‐party assay of I‐125 seeds used for prostate implants
The purpose of this work is to describe a method and apparatus that can be used to confirm the source strength of a large number of I‐125 seeds while maintaining sterility, accuracy, reproducibility, and time efficiency. Source strengths ranging from 0.395 to 0.504 U/seed were available for this stu...
Autores principales: | Muryn, John S., Wilkinson, D. Allan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689901/ https://www.ncbi.nlm.nih.gov/pubmed/28291924 http://dx.doi.org/10.1002/acm2.12000 |
Ejemplares similares
-
MR‐guided 125I seed implantation treatment for maxillofacial malignant tumor
por: Wang, Ying, et al.
Publicado: (2020) -
Method for verifying the air kerma strength of I‐125 plaques for the treatment of ocular melanoma
por: Zimmermann, L. W., et al.
Publicado: (2014) -
Dosimetric characterization of GMS BT‐125‐1 (125)I radioactive seed with Monte Carlo simulations and experimental measurement
por: Zhao, Nan, et al.
Publicado: (2017) -
Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021) -
Practical considerations in the selection of seed strength for prostate implants
por: Elliott, Sarah L, et al.
Publicado: (2015)